Antibody Drug Conjugates Contract Manufacturing Market Analysis and Forecast (2025-2030) by Linker, Condition, End Use and Region - Industry Set to Experience 11.8% CAGR Over the Forecast Period
November 22, 2024 07:14 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Manufacturing Market by Linker, Condition, End Use - Global Forecast 2025-2030" report has been added to ...
Lifecore Biomedical Hosts Virtual Investor Day
November 21, 2024 16:17 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
High Potency API Contract Manufacturing Market Forecast, 2025-2030 - Rising Demand for Oncology Drugs and Advancements in Manufacturing Technology Driving the Industry at 10.98% CAGR
November 14, 2024 04:58 ET
|
Research and Markets
Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market Size, Share & Trends Analysis by Product (Innovative, Generic), Dosage Form (Injectable, Creams),...
Semi-Solid Dosage CDMO Market Report 2024-2030: The Lubrizol Corporation, Cambrex Corporation, and Contract Pharmaceuticals Dominate the Competitive Landscape
November 13, 2024 11:32 ET
|
Research and Markets
Dublin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The "Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis by Route of Administration (Topical, Transdermal, Others), Product, Service, End-use,...
Lifecore Biomedical to Present at Stephens Annual Investment Conference
November 12, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
November 07, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Pharmaceutical Contract Manufacturing Market Report 2024-2034 - Patent Expiry and Increasing Demand for Generic Drugs Drive Market Growth
November 05, 2024 11:02 ET
|
Research and Markets
Dublin, Nov. 05, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the...
Pharmaceutical Isolators Industry Report 2025-2030: Market to Grow by $3.54 Billion, at a CAGR of 7.98%, with Azbil, Comecer, Getinge, Jacomex, and SKAN Dominating the Competition
November 05, 2024 04:11 ET
|
Research and Markets
Dublin, Nov. 05, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Isolator Market by Product Type, Application, System Type, End User, Technology, Material, Pressure, Component - Global Forecast...
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
November 04, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development...
Healthcare Contract Development and Manufacturing Organization (CDMO) Strategic Business Research Report 2023-2030
October 16, 2024 05:02 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Healthcare Contract Development and Manufacturing Organization - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...